In the APP/PS1 model, somatostatin (SOM) interneurons near amyloid plaques become hyperactive, while parvalbumin interneurons are hypoactive, leading to an excitation-inhibition imbalance (Algamal et al., 2022)
This contributes to both its healing properties (maintaining blood supply to injured tissue) and its protective effects against various forms of organ damage
What the evidence supports today is biological plausibility worth a proper trial
Regular exercise and stress management techniques can also support a healthy gut microbiome
Advantage: BPC-157 for rapid, targeted results
What makes BPC-157 distinctive among research peptides is a combination of three properties rarely found together: it has no sequence homology to any other known peptide, it is completely stable in human gastric acid for at least 24 hours (unlike most growth factors and peptide analogues, which are rapidly degraded), and it remains active across an exceptionally broad effective dose range from nanogram to microgram per kilogram bodyweight in pre-clinical models without any known toxic dose having been established in animal studies to date
